Literature DB >> 23174712

Personalized medicine of esophageal cancer.

Lei Wang1, Hui-Yi Yang, Yong-Qing Zheng.   

Abstract

The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend. This review presents several biomarkers of esophageal cancer, including chemotherapy-related biomarkers and targeted drug-related biomarkers, and the correlation of these biomarkers with drug response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174712     DOI: 10.4103/0973-1482.103510

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development.

Authors:  Anja Klussmeier; Stefan Aurich; Lars Niederstadt; Bertram Wiedenmann; Carsten Grötzinger
Journal:  Biomedicines       Date:  2022-02-24

2.  Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus.

Authors:  Yingying Xu; Huanyu Zhao; Yusuo Tong; Wanwei Wang; Jing Huang; Weiguo Zhu
Journal:  Int J Gen Med       Date:  2021-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.